03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Rare diseases
Dr Su Lwin
Senior Research Fellow at King's College London and Consultant Dermatologist at Guy's and St Thomas'
press citation on 1 topic since 9 Dec 2025 · last quoted 9 Dec 2025
02 Quoted on · 1 of 29 topics
Dr Su Lwin: key facts
- Kind of voice
- Clinician
- Role
- Senior Research Fellow at King's College London and Consultant Dermatologist at Guy's and St Thomas'
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 9 Dec 2025
04 The signal · where Dr Su Lwin sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Clara Cali MellaSector leaderdata strategy lead at Bayer1
- 25=Eslam KatabSector leaderglobal clinical development manager at Sandoz1
- 25=Dr Su LwinClinicianSenior Research Fellow at King's College London and Consultant Dermatologist at Guy's and St Thomas'1
- 25=Suma ShankarAcademicChief of the Genomic Medicine Division in the Department of Pediatrics and director of Precision Genomics, professor in the Departments of Pediatrics and Ophthalmology1
- 25=Van Kim MaAcademicDevelopmental and behavioral pediatrician1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Dr Su Lwin has said
- kcl.ac.uk1
Where Dr Su Lwin has been quoted
Verbatim
“My work aims to bridge the gap between rare and common skin diseases. By repurposing existing drugs that are already licensed for use for other conditions, we can accelerate therapeutic innovation and hopefully bring much-needed treatments to the people who need them sooner.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.